General Notices

• Notice of Information: National Institute of Biomedical Imaging and Bioengineering (NIBIB) to Issue Single Source Award to Support NeuroImaging Tools and Resources Collaboratory (NITRC)
  (NOT-EB-23-011)
  National Institute of Biomedical Imaging and Bioengineering
  

• Notice of Pre-Application Webinar for RFA-ES-23-007 "Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)"
  (NOT-ES-23-014)
  National Institute of Environmental Health Sciences
  

• Notice of a Question and Answer "Office Hour" with NIGMS Staff for Bridges to the Baccalaureate and Bridges to the Doctorate Applicants
  (NOT-GM-23-050)
  National Institute of General Medical Sciences
  

• Notice of Technical Assistance Webinar for RFA-MH-24-150, "Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required)"
  (NOT-MH-23-365)
  National Institute of Mental Health
  

• Request for Information (RFI) on Opportunities for Biomarker Research in Amyotrophic Lateral Sclerosis (ALS)
  (NOT-NS-23-097)
  National Institute of Neurological Disorders and Stroke
  

Notice of Changes to Funding Opportunities

• Notice of Change to Eligibility Requirements for Program Directors/Principal Investigators in PAR-22-227, NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed)
  (NOT-AG-23-042)
  National Institute on Aging
  

• Notice of Need to Expire and Reissue NOT-AT-21-013 "Notice of Special Interest: National Center for Complementary and Integrative Health (NCCIH) T32 Supplement Program for Pre and Postdoctoral Candidates from Diverse Backgrounds" to Change the Due Dates
  (NOT-AT-24-011)
  National Center for Complementary and Integrative Health
  

• Notice to Extend the Response date for NOT-DC-23-013, "Request for Information (RFI): Inviting Input Regarding NIDCDs Research Directions to Support Communication in Minimally Verbal/Non-Speaking People"
  (NOT-DC-23-014)
  National Institute on Deafness and Other Communication Disorders
  

• Notice of Change to Key Dates for PAR-23-029, NCMRR Early Career Research Award (R03 Clinical Trial Optional)
  (NOT-HD-23-019)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice NICHD Participation on PAR-23-190: "Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, treatment and Care in Low- and Middle-Income Countries (R01 - Clinical Trial Optional)
  (NOT-HD-23-020)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Correction to Eligibility Criteria for RFA-HL-23-007 Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
  (NOT-HL-23-100)
  National Heart, Lung, and Blood Institute
  

• Notice of Change: Extension of PAR-20-285 "NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)"
  (NOT-NS-23-094)
  National Institute of Neurological Disorders and Stroke
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Limited Competition: Clinical Centers for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (UG1 Clinical Trial Not Allowed)
  (NOT-HD-23-022)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Limited Competition: Data Coordinating Center for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (U24 Clinical Trial Not Allowed)
  (NOT-HD-23-023)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Diagnostic Centers of Excellence (U01 - Clinical Trial Not Allowed)
  (NOT-NS-23-096)
  National Institute of Neurological Disorders and Stroke
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Administrative Supplement for Collaborative Projects Supported by the NIAID/RNCP
  (NOT-AI-23-044)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Special Interest (NOSI): Administrative Supplements to support research by Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentors at NIMHD-Funded Research Centers in Minority Institutions (RCMI)
  (NOT-MD-23-016)
  National Institute on Minority Health and Health Disparities
  Office of the Director, NIH
  

• Notice of Special Interest (NOSI): Innovative Technologies to develop novel tools to prevent and treat HIV in underserved populations
  (NOT-MH-23-200)
  National Institute of Mental Health
  

Funding Opportunities

• Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
  (PAR-23-238)
  National Institute of Mental Health
  Application Receipt Date(s): September 07, 2026
  
  

• Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
  (PAR-23-239)
  National Institute of Mental Health
  Application Receipt Date(s): September 07, 2026
  
  

• Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
  (PAR-23-246)
  National Cancer Institute
  Application Receipt Date(s): May 04, 2026
  
  

• Health Equity and the Cost of Novel Treatments for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)
  (RFA-AG-24-050)
  National Institute on Aging
  Application Receipt Date(s): October 31, 2023
  
  

• NIH-DoD-VA Pain Management Collaboratory Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required)
  (RFA-AT-24-004)
  National Center for Complementary and Integrative Health
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Application Receipt Date(s): September 13, 2023
  
  

• Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed)
  (RFA-CA-23-036)
  National Cancer Institute
  Application Receipt Date(s): November 15, 2023
  
  

• Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed)
  (RFA-CA-23-037)
  National Cancer Institute
  Application Receipt Date(s): November 15, 2023
  
  

• HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed)
  (RFA-DA-24-063)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): February 01, 2024
  
  

• HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed)
  (RFA-DA-24-064)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): February 01, 2024
  
  

• Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)
  (RFA-DA-25-014)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 14, 2025
  
  

• Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required)
  (RFA-DA-25-019)
  National Institute on Drug Abuse
  Application Receipt Date(s): March 19, 2025
  
  

• Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
  (RFA-DA-25-020)
  National Institute on Drug Abuse
  Application Receipt Date(s): March 19, 2025
  
  

• The Role of Sleep Deficiency in Persons with Type 1 Diabetes: Sleep, Glycemic Control, and Cardiovascular Risk (R01 Clinical Trial Optional)
  (RFA-HL-24-008)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): October 11, 2023
  
  

• The Role of Sleep Deficiency in Persons with Type 1 Diabetes: Sleep, Glycemic Control, and Cardiovascular Risk (R34 Clinical Trial Optional)
  (RFA-HL-24-009)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): October 11, 2023
  
  

• NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed)
  (RFA-NS-24-014)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): February 10, 2025